WASHINGTON Copaxone, a blockbuster drug manufactured by Israel’s Teva Industries, has proven to be ineffective for the treatment of amyotrophic lateral sclerosis, according to the company. Copaxone, ...
Share on Pinterest Federal regulators have approved a new oral medication to treat ALS. Comezora/Getty Images About 30,000 people in the United States are living with amyotrophic lateral sclerosis ...
SEATTLE, Sept. 20, 2017 /PRNewswire/ -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing mRNA treatments for life-threatening inherited liver diseases in children, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback